PLCG1 and renal cell carcinoma: This suggests AKT, PLCγ-1, p38α and JNK/paxillin signaling pathways, which are described as downstream targets of CaSR [27,36,39,40], being the crucial pathways in the CaSR signaling in RCC cells promoting bone specific metastasis (Figure 6).